Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FB4UZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,449
Award facts
- Contract value 100% obligated
- $20,449.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,449.43 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mls, a biologic immunosuppressant medication used to treat autoimmune conditions. This competitively awarded, non-set-aside contract utilizes a firm fixed-price structure with an ultimate completion date of January 14, 2026. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a critical vendor in the federal pharmaceutical supply chain, AmerisourceBergen provides a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting history demonstrates consistent capability in fulfilling open competition procurement requirements for essential medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FB4UZ?
SPE2DR26FB4UZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FB4UZ worth?
The government has obligated $20,449 on SPE2DR26FB4UZ.
Is contract SPE2DR26FB4UZ an order under another contract?
Yes. SPE2DR26FB4UZ is a delivery order under SPE2DR25D2208, an indefinite delivery contract.
Was contract SPE2DR26FB4UZ competed?
The extent of competition for SPE2DR26FB4UZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award